Alpha Tau Medical Ltd. (DRTSW)

NASDAQ: DRTSW · Real-Time Price · USD · Warrants
0.3554
+0.0354 (11.06%)
At close: Dec 5, 2025, 4:00 PM EST
0.3500
-0.0054 (-1.52%)
After-hours: Dec 5, 2025, 4:00 PM EST
11.06%
Market Cap331.68M
Revenue (ttm)n/a
Net Income (ttm)-39.97M
Shares Out 85.26M
EPS (ttm)-0.52
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume20,077
Open0.3100
Previous Close0.3200
Day's Range0.2810 - 0.3554
52-Week Range0.1300 - 0.5000
Beta1.06
Analystsn/a
Price Targetn/a
Earnings Daten/a

About DRTSW

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 125
Stock Exchange NASDAQ
Ticker Symbol DRTSW
Full Company Profile

News

There is no news available yet.